相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer
Charlotte Fribbens et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti et al.
MOLECULAR ONCOLOGY (2016)
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
Christopher D. Richardson et al.
NATURE BIOTECHNOLOGY (2016)
Interplay between steroid hormone activation of the unfolded protein response and nuclear receptor action
Xiaobin Zheng et al.
STEROIDS (2016)
Anticipatory UPR Activation: A Protective Pathway and Target in Cancer
David J. Shapiro et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Jill M. Spoerke et al.
NATURE COMMUNICATIONS (2016)
Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations
Brendon Ladd et al.
ONCOTARGET (2016)
Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
Sean W Fanning et al.
eLife (2016)
Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response
Xiaobin Zheng et al.
Oncotarget (2016)
Progesterone action in breast, uterine, and ovarian cancers
Caroline H. Diep et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
Cory Smith et al.
MOLECULAR THERAPY (2015)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Takeshi Maruyama et al.
NATURE BIOTECHNOLOGY (2015)
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
Van Trung Chu et al.
NATURE BIOTECHNOLOGY (2015)
Estrogen receptor a inhibitor activates the unfolded protein response, blocks protein synthesis, and induces tumor regression
Neal D. Andruska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
Gaia Schiavon et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Puping Liang et al.
PROTEIN & CELL (2015)
Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer
N. Andruska et al.
ONCOGENE (2015)
Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells
Qiupeng Zheng et al.
BIOTECHNIQUES (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
Yuyu Niu et al.
CELL (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Seung Woo Cho et al.
GENOME RESEARCH (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
Keren Merenbakh-Lamin et al.
CANCER RESEARCH (2013)
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang et al.
CELL (2013)
Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
Gerald Schwank et al.
CELL STEM CELL (2013)
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Yuxuan Wu et al.
CELL STEM CELL (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor
Hisham Mohammed et al.
CELL REPORTS (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
A Competitive Inhibitor That Reduces Recruitment of Androgen Receptor to Androgen-responsive Genes
Milu T. Cherian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The biology of progesterone receptor in the normal mammary gland and in breast cancer
Alison E. Obr et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58IPK
Danmei Gao et al.
LABORATORY INVESTIGATION (2012)
Evaluation of a Luciferase-Based Reporter Assay as a Screen for Inhibitors of Estrogen-ERα-Induced Proliferation of Breast Cancer Cells
Neal Andruska et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer
Changyu Shen et al.
BMC SYSTEMS BIOLOGY (2011)
Fulvestrant A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
Jamie D. Croxtall et al.
DRUGS (2011)
Prognosis of Hormone-Dependent Breast Cancers: Implications of the Presence of Dysfunctional Transcriptional Networks Activated by Insulin via the Immune Transcription Factor T-bet
Kasi McCune et al.
CANCER RESEARCH (2010)
The Effect of Low Dose Zinc Supplementation to Serum Estrogen and Progesterone Levels in Post-menopausal Women
Fusun Sunar et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2008)
Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer
Peter McCormack et al.
CLINICAL BREAST CANCER (2008)
A new small molecule inhibitor of estrogen receptor α binding to estrogen response elements blocks estrogen-dependent growth of cancer cells
Chengjian Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Progressive loss of estrogen receptor α cofactor recruitment in endocrine resistance
Catherine Naughton et al.
MOLECULAR ENDOCRINOLOGY (2007)
Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death
Jian-Hua Zhou et al.
STEROIDS (2007)
Estrogen-regulated gene networks in human breast cancer cells: Involvement of E2F1 in the regulation of cell proliferation
Joshua D. Stender et al.
MOLECULAR ENDOCRINOLOGY (2007)
GRP78 induction in cancer: Therapeutic and prognostic implications
Amy S. Lee
CANCER RESEARCH (2007)
Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer
Jun Zhang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Altered target gene regulation controlled by estrogen receptor-α concentration
AM Fowler et al.
MOLECULAR ENDOCRINOLOGY (2006)
Ero1-Lα plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia:: implication for cancer
D May et al.
ONCOGENE (2005)
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death
M Obrero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Molecular determinants for the tissue specificity of SERMs
YF Shang et al.
SCIENCE (2002)
分享论文
